- Randomized multicenter phase II trial of subcutaneous recombinant human interleukin-12 versus interferon-alpha 2a for patients with advanced renal cell carcinoma. Motzer, R.J., Rakhit, A., Thompson, J.A., Nemunaitis, J., Murphy, B.A., Ellerhorst, J., Schwartz, L.H., Berg, W.J., Bukowski, R.M. J. Interferon Cytokine Res. (2001)